Zacks Research Expects Weaker Earnings for DENTSPLY SIRONA

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) – Stock analysts at Zacks Research decreased their Q1 2026 earnings per share (EPS) estimates for shares of DENTSPLY SIRONA in a note issued to investors on Thursday, March 19th. Zacks Research analyst Team now anticipates that the medical instruments supplier will post earnings of $0.32 per share for the quarter, down from their prior forecast of $0.38. Zacks Research currently has a “Hold” rating on the stock. The consensus estimate for DENTSPLY SIRONA’s current full-year earnings is $1.84 per share. Zacks Research also issued estimates for DENTSPLY SIRONA’s Q2 2026 earnings at $0.38 EPS, Q3 2026 earnings at $0.36 EPS, Q4 2026 earnings at $0.38 EPS, FY2026 earnings at $1.43 EPS, Q1 2027 earnings at $0.33 EPS, Q2 2027 earnings at $0.40 EPS, Q3 2027 earnings at $0.43 EPS, FY2027 earnings at $1.56 EPS and FY2028 earnings at $1.73 EPS.

Several other analysts also recently issued reports on the company. Wells Fargo & Company lifted their target price on DENTSPLY SIRONA from $12.00 to $13.00 and gave the company an “equal weight” rating in a research note on Friday, February 27th. Bank of America raised shares of DENTSPLY SIRONA from a “neutral” rating to a “buy” rating and increased their price objective for the company from $13.00 to $17.00 in a report on Thursday, February 19th. Barrington Research boosted their target price on shares of DENTSPLY SIRONA from $14.00 to $17.00 and gave the stock an “outperform” rating in a report on Monday, March 2nd. UBS Group cut their target price on shares of DENTSPLY SIRONA from $17.00 to $16.00 and set a “buy” rating for the company in a research note on Tuesday, February 3rd. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of DENTSPLY SIRONA in a report on Wednesday, January 21st. Three analysts have rated the stock with a Buy rating, ten have given a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, DENTSPLY SIRONA has a consensus rating of “Hold” and a consensus target price of $14.42.

DENTSPLY SIRONA Price Performance

Shares of DENTSPLY SIRONA stock opened at $11.26 on Friday. The company has a quick ratio of 1.03, a current ratio of 1.51 and a debt-to-equity ratio of 1.50. DENTSPLY SIRONA has a 52 week low of $9.85 and a 52 week high of $17.18. The stock’s 50-day simple moving average is $12.68 and its 200-day simple moving average is $12.34. The company has a market capitalization of $2.25 billion, a price-to-earnings ratio of -3.75, a PEG ratio of 1.36 and a beta of 0.97.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its earnings results on Thursday, February 26th. The medical instruments supplier reported $0.27 earnings per share for the quarter, missing the consensus estimate of $0.28 by ($0.01). The firm had revenue of $961.00 million during the quarter, compared to the consensus estimate of $926.40 million. DENTSPLY SIRONA had a positive return on equity of 18.85% and a negative net margin of 16.25%.The company’s quarterly revenue was up 6.2% on a year-over-year basis. During the same period in the prior year, the company posted $0.26 EPS. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS.

Institutional Investors Weigh In On DENTSPLY SIRONA

Several institutional investors have recently modified their holdings of XRAY. Daiwa Securities Group Inc. increased its position in shares of DENTSPLY SIRONA by 2.9% during the 4th quarter. Daiwa Securities Group Inc. now owns 26,814 shares of the medical instruments supplier’s stock valued at $306,000 after purchasing an additional 767 shares during the last quarter. Arizona State Retirement System boosted its stake in DENTSPLY SIRONA by 1.4% during the third quarter. Arizona State Retirement System now owns 58,952 shares of the medical instruments supplier’s stock worth $748,000 after buying an additional 807 shares during the period. True Wealth Design LLC boosted its stake in DENTSPLY SIRONA by 49.7% during the third quarter. True Wealth Design LLC now owns 3,557 shares of the medical instruments supplier’s stock worth $45,000 after buying an additional 1,181 shares during the period. Sivia Capital Partners LLC increased its position in DENTSPLY SIRONA by 5.3% during the third quarter. Sivia Capital Partners LLC now owns 25,774 shares of the medical instruments supplier’s stock valued at $327,000 after acquiring an additional 1,293 shares during the last quarter. Finally, Empowered Funds LLC raised its stake in shares of DENTSPLY SIRONA by 8.8% in the first quarter. Empowered Funds LLC now owns 16,324 shares of the medical instruments supplier’s stock valued at $244,000 after acquiring an additional 1,320 shares during the period. 95.70% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other DENTSPLY SIRONA news, Director James D. Forbes acquired 5,000 shares of the company’s stock in a transaction on Monday, March 9th. The stock was acquired at an average cost of $12.48 per share, with a total value of $62,400.00. Following the purchase, the director directly owned 10,000 shares of the company’s stock, valued at approximately $124,800. This represents a 100.00% increase in their position. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Gregory T. Lucier bought 27,555 shares of DENTSPLY SIRONA stock in a transaction dated Monday, March 2nd. The stock was acquired at an average price of $14.24 per share, for a total transaction of $392,383.20. Following the completion of the acquisition, the director owned 27,555 shares in the company, valued at approximately $392,383.20. The trade was a ∞ increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Over the last three months, insiders purchased 70,000 shares of company stock valued at $956,437. 0.50% of the stock is currently owned by insiders.

About DENTSPLY SIRONA

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.